PubMed ID: 34267921
Author(s): Elnahry AG, Talbet JH, Elnahry GA. Methotrexate monotherapy for unilateral moderately active thyroid-related eye disease. Clin Case Rep. 2021 Jul 9;9(7):e04559. doi: 10.1002/ccr3.4559. eCollection 2021 Jul. PMID 34267921
Journal: Clinical Case Reports, Volume 9, Issue 7, Jul 2021
A type 1 diabetic patient with unilateral active thyroid-related eye disease was intolerant to systemic steroid therapy due to uncontrollable blood sugar levels. She was treated with low-dose methotrexate monotherapy, which resulted in a marked improvement of her condition with no adverse events.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.